PRKAA1 and type 2 diabetes mellitus: It can be seen that the insulin signaling mechanism of patients with type 2 diabetes is damaged; that is, the expression of messenger ribonucleic acid (mRNA) or protein of many molecules in the signaling path is damaged, but the noninsulin signaling mechanism of AMPK in these patients is not damaged.